[
  {
    "drug": "Acetaminophen (Tylenol)",
    "population": "Adult",
    "page": 231,
    "text": "For mild to moderate pain scales of 1-5 or in moderate to severe pain where other medications are contraindicated or deferred. Tylenol, 1 g mIV/IO infusi on over fifteen (15) minutes. Single dose only",
    "html": "<div class='proto'>For mild to moderate pain scales of 1-5 or in moderate to severe pain where other medications are contraindicated or deferred. Tylenol, <b>1 g</b> mIV/<b>IO</b> infusi on over fifteen (15) minutes. Single dose only</div>"
  },
  {
    "drug": "Acetaminophen (Tylenol)",
    "population": "Pediatric",
    "page": 231,
    "text": "For mild to moderate pain scales of 1-5 or in moderate to severe pain where other medications are contraindicated or deferred. 2 years to 14 years: Tylenol, 15mg/kg to max of 1000mg or 1 g mIV/IO infusi on over fifteen (15) minutes. Single dose only",
    "html": "<div class='proto'>For mild to moderate pain scales of 1-5 or in moderate to severe pain where other medications are contraindicated or deferred. 2 years to 14 years: Tylenol, <b>15mg/kg</b> to <b>max of <b>1000mg</b> or <b>1 g</b></b> mIV/<b>IO</b> infusi on over fifteen (15) minutes. Single dose only</div>"
  },
  {
    "drug": "Adenosine (Adenocard)",
    "population": "Adult",
    "page": 231,
    "text": "Stable narrow-complexSVT or Widecomplex tachycardia: Adenosine, 6 mg rapid IVP followed immediately by 20 cc NS bolus, and Adenosine, 12 mg rapid IVP followed immediately by 20 cc NS bolus if patient does not convert. Mayrepe at one (1) time. Albuterol (Proventil) Aerosolized Soluti on - Adult (LALS, ALS) Albuterol, 2.5 mg nebulized, mayrepe at two (2) times. Albuterol (Proventil) Metered-DoseInhaler (MDI) - Adult (BLS, LALS, ALS) AlbuterolMDI, four (4) puffs every 10 minutes for continued shortness of breath and wheezing.",
    "html": "<div class='proto'>Stable narrow-complexSVT or Widecomplex tachycardia: Adenosine, <b>6 mg</b> rapid <b>IVP</b> followed immediately by <b>20 cc</b> NS bolus, and Adenosine, <b>12 mg</b> rapid <b>IVP</b> followed immediately by <b>20 cc</b> NS bolus if patient does not convert. Mayrepe at one (1) time. Albuterol (Proventil) Aerosolized Soluti on - Adult (LALS, ALS) Albuterol, <b>2.5 mg</b> <b>nebulized</b>, mayrepe at two (2) times. Albuterol (Proventil) Metered-DoseInhaler (MDI) - Adult (BLS, LALS, ALS) AlbuterolMDI, four (4) puffs every 10 minutes for continued shortness of breath and wheezing.</div>"
  },
  {
    "drug": "Albuterol (Proventil)",
    "population": "Pediatric",
    "page": 231,
    "text": "Albuterol, 2.5 mg nebulized, mayrepe at two (2) times. Albuterol (Proventil) Metered-DoseInhaler (MDI) - Pediatric (BLS, LALS, ALS) AlbuterolMDI, four (4) puffs every 10 minutes for continued shortness of breath and wheezing. Aspir in, chewable -Adult (LALS, ALS) Aspir in, 325 mg PO chewed (one (1) adultn on-enteric coated aspir in) or four (4) chewable 81 mg aspir in.",
    "html": "<div class='proto'>Albuterol, <b>2.5 mg</b> <b>nebulized</b>, mayrepe at two (2) times. Albuterol (Proventil) Metered-DoseInhaler (MDI) - Pediatric (BLS, LALS, ALS) AlbuterolMDI, four (4) puffs every 10 minutes for continued shortness of breath and wheezing. Aspir in, chewable -Adult (LALS, ALS) Aspir in, <b>325 mg</b> <b>PO</b> chewed (one (1) adultn on-enteric coated aspir in) or four (4) chewable <b>81 mg</b> aspir in.</div>"
  },
  {
    "drug": "Atropine (ALS)",
    "population": "Adult",
    "page": 232,
    "text": "Atropine, 1 mg IV/IO. Mayrepe at every five (5) minutesup to a maximum of 3 mg or 0.04 mg/kg. Organophosphate poisoning: Atropine, 2 mg IV/IO, repe at at 2 mg increments every five (5) minutes if patient remains symptomatic.",
    "html": "<div class='proto'>Atropine, <b>1 mg</b> <b>IV/IO</b>. Mayrepe at every five (5) minutesup to a <b>maximum of <b>3 mg</b> or <b>0.04 mg</b></b>/kg. Organophosphate poisoning: Atropine, <b>2 mg</b> <b>IV/IO</b>, repe at at <b>2 mg</b> increments every five (5) minutes if patient remains symptomatic.</div>"
  },
  {
    "drug": "Atropine",
    "population": "Pediatric",
    "page": 232,
    "text": "Organophosphate poisoning - Pediatrics lessthan 14 years of age: Atropine, 0.05 mg/kgIV/IO not to exceed adult dose of 2 mg, repe at at 0.1 mg/kgincrements every five (5) minutes if patient remains symptomatic. Buprenorphine-Naloxone (Suboxone \u00ae)-Adult (ALS): Opioid Withdrawal- Clinical Opioid Withdrawal Scale \u2265 8: Buprenorphine-Naloxone, 16 mg/4mg sublingual, mayrepe at at 8 mg/2mg sublingual after ten (10) minutes if patient remains symptomatic, to a maximum total dose of 24 mg/6mg.",
    "html": "<div class='proto'>Organophosphate poisoning - Pediatrics lessthan 14 years of age: Atropine, <b>0.05 mg/kg</b><b>IV/IO</b> <b>not to exceed adult dose of <b>2 mg</b>, repe at at <b>0.1 mg</b></b>/kgincrements every five (5) minutes if patient remains symptomatic. Buprenorphine-Naloxone (Suboxone \u00ae)-Adult (ALS): Opioid Withdrawal- Clinical Opioid Withdrawal Scale \u2265 8: Buprenorphine-Naloxone, <b>16 mg</b>/<b>4mg</b> sublingual, mayrepe at at <b>8 mg</b>/<b>2mg</b> sublingual after ten (10) minutes if patient remains symptomatic, to a <b>maximum total dose of <b>24 mg</b>/<b>6mg</b></b>.</div>"
  },
  {
    "drug": "Calcium Chloride",
    "population": "Adult",
    "page": 232,
    "text": "Calcium Channel Blocker Poisonings Calcium Chloride, 1 g m (10 ml of a 10% soluti on) IV/IO. For cardiac arrest with suspected hypocalcemia, hyperkalemia, hypermagnesemia or calcium channel blocker poisoning Calcium Chloride, 1 g m (10 ml of a 10% soluti on) IV/IO. For EndStage Renal Disease (ESRD) patients on dialysis with suspected hyperkalemia and hemodynamic instability with documented sinus bradycardia,3rd degreeAV Block, 2nd degree TypeIIAV Block, slowjunctional and ventricular escape rhythms, or slowatrial fibrillati on. (Basehospital order only). Calcium Chloride, 1 g m (10 ml of a 10% soluti on) IV/IO",
    "html": "<div class='proto'>Calcium Channel Blocker Poisonings Calcium Chloride, <b>1 g</b> m (<b>10 ml</b> of a 10% soluti on) <b>IV/IO</b>. For cardiac arrest with suspected hypocalcemia, hyperkalemia, hypermagnesemia or calcium channel blocker poisoning Calcium Chloride, <b>1 g</b> m (<b>10 ml</b> of a 10% soluti on) <b>IV/IO</b>. For EndStage Renal Disease (ESRD) patients on dialysis with suspected hyperkalemia and hemodynamic instability with documented sinus bradycardia,3rd degreeAV Block, 2nd degree TypeIIAV Block, slowjunctional and ventricular escape rhythms, or slowatrial fibrillati on. (Basehospital order only). Calcium Chloride, <b>1 g</b> m (<b>10 ml</b> of a 10% soluti on) <b>IV/IO</b></div>"
  },
  {
    "drug": "Calcium Chloride",
    "population": "Pediatric",
    "page": 233,
    "text": "Calcium Channel Blocker Poisonings Calcium Chloride, 20 mg/kgIV/IO over five (5) minutes.",
    "html": "<div class='proto'>Calcium Channel Blocker Poisonings Calcium Chloride, <b>20 mg/kg</b><b>IV/IO</b> over five (5) minutes.</div>"
  },
  {
    "drug": "Hypoglycemia",
    "population": "Adult",
    "page": 233,
    "text": "Dextrose 10% /250 ml (D10W 25 g m) IV/IO Bolus",
    "html": "<div class='proto'>Dextrose 10% /<b>250 ml</b> (D10W <b>25 g</b> m) <b>IV/IO</b> Bolus</div>"
  },
  {
    "drug": "Dextrose",
    "population": "Pediatric",
    "page": 233,
    "text": "Hypoglycemia - Neonates (0 - 4 weeks) with bloodg lucose lessthan 35 mg/dL or pediatric patients (morethan 4 weeks) with g lucose lessthan 60 mg/dL: Dextrose 10%/250 ml (D10W 25 g m) 0.5 g m/kg (5 ml/kg) IV/IO",
    "html": "<div class='proto'>Hypoglycemia - Neonates (0 - 4 weeks) with bloodg lucose lessthan <b>35 mg</b>/dL or pediatric patients (morethan 4 weeks) with g lucose lessthan <b>60 mg</b>/dL: Dextrose 10%/<b>250 ml</b> (D10W <b>25 g</b> m) <b>0.5 g</b> m/kg (<b>5 ml/kg</b>) <b>IV/IO</b></div>"
  },
  {
    "drug": "Diazepam",
    "population": "Adult",
    "page": 233,
    "text": "Seizures: Diazepam , 5 mg IV/IO, single dose only Diazepam 10mg IM, single dose only",
    "html": "<div class='proto'>Seizures: Diazepam , <b>5 mg</b> <b>IV/IO</b>, single dose only Diazepam <b>10mg</b> <b>IM</b>, single dose only</div>"
  },
  {
    "drug": "Diazepam",
    "population": "Pediatric",
    "page": 233,
    "text": "Seizures: Diazepam 0.1mg/kgIV/IO, single dose only, not to exceed adult dose of 5mg Diazepam 0.2mg/kgIM, single dose only, not to exceed adult dose of 10mg",
    "html": "<div class='proto'>Seizures: Diazepam <b>0.1mg/kg</b><b>IV/IO</b>, single dose only, <b>not to exceed adult dose of <b>5mg</b> Diazepam <b>0.2mg</b></b>/kgIM, single dose only, <b>not to exceed adult dose of <b>10mg</b></b></div>"
  },
  {
    "drug": "Diphenhydramine",
    "population": "Adult",
    "page": 233,
    "text": "Diphenhydramine, 25 mg IV/IO Diphenhydramine, 50 mg IM",
    "html": "<div class='proto'>Diphenhydramine, <b>25 mg</b> <b>IV/IO</b> Diphenhydramine, <b>50 mg</b> <b>IM</b></div>"
  },
  {
    "drug": "Diphenhydramine",
    "population": "Pediatric",
    "page": 233,
    "text": "Allergic reacti on: 2 years to 14 years Diphenhydramine, 1 mg/kgslowIV/IO, not to exceed adult dose of 25 mg, or Diphenhydramine, 2 mg/kgIM not to exceed adult dose of 50 mg IM.",
    "html": "<div class='proto'>Allergic reacti on: 2 years to 14 years Diphenhydramine, <b>1 mg/kg</b>slowIV/<b>IO</b>, <b>not to exceed adult dose of <b>25 mg</b>, or Diphenhydramine, <b>2 mg/kg</b><b>IM</b> not to exceed adult dose of <b>50 mg</b></b> <b>IM</b>.</div>"
  },
  {
    "drug": "Epinephrine (1 mg/ml)",
    "population": "Adult",
    "page": 234,
    "text": "Severe Bronchospasm, Asthma Attack, Pending Respiratory Failure, Severe Allergic Reactions: Epinephrine, 0.3 mg IM. Mayrepe at after 15 minutesone (1) time if symptoms do not improve.",
    "html": "<div class='proto'>Severe Bronchospasm, Asthma Attack, Pending Respiratory Failure, Severe Allergic Reactions: Epinephrine, <b>0.3 mg</b> <b>IM</b>. Mayrepe at after 15 minutesone (1) time if symptoms do not improve.</div>"
  },
  {
    "drug": "Epinephrine (0.1 mg/ml)",
    "population": "Adult",
    "page": 234,
    "text": "For persistent severe anaphylactic reacti on: Epinephrine (0.1 mg/ml), 0.1 mg slow IV P/IO. Mayrepe at every five (5) minutes as needed to total dosage of 0.5 mg. Cardiac Arrest, Asystole, PEA: Epinephrine (0.1 mg/ml), 1 mg IV/IO.",
    "html": "<div class='proto'>For persistent severe anaphylactic reacti on: Epinephrine (<b>0.1 mg</b>/ml), <b>0.1 mg</b> slow <b>IV</b> P/<b>IO</b>. Mayrepe at every five (5) minutes as needed to total dosage of <b>0.5 mg</b>. Cardiac Arrest, Asystole, PEA: Epinephrine (<b>0.1 mg</b>/ml), <b>1 mg</b> <b>IV/IO</b>.</div>"
  },
  {
    "drug": "Epinephrine (0.01 mg/ml)",
    "population": "Adult",
    "page": 234,
    "text": "Postresuscitati on, persistent profound nontraumatic shock and hypotensi on, and for persistent shockdue to trauma where cardiac arrest is imminent:(PushDose Epinephrine). Prep are Epinephrine 0.01 mg/ml soluti on by mixing 9 ml of normal saline with 1 ml of Epinephrine 0.1 mg/ml in a 10 ml syringe. Administer 1 ml every one (1) to five (5) minutes titrated to maintainSBP morethan 90 mmHg.",
    "html": "<div class='proto'>Postresuscitati on, persistent profound nontraumatic shock and hypotensi on, and for persistent shockdue to trauma where cardiac arrest is imminent:(PushDose Epinephrine). Prep are Epinephrine <b>0.01 mg</b>/ml soluti on by mixing <b>9 ml</b> of normal saline with <b>1 ml</b> of Epinephrine <b>0.1 mg</b>/ml in a <b>10 ml</b> syringe. Administer <b>1 ml</b> every one (1) to five (5) minutes titrated to maintainSBP morethan 90 mmHg.</div>"
  },
  {
    "drug": "Epinephrine (0.1 mg/ml)",
    "population": "Pediatric",
    "page": 235,
    "text": "Anaphylactic reacti on (no palpable radial pulse and depressed level of consciousness): Epinephrine (0.1 mg/ml), 0.01 mg/kgIV/IO, no morethan 0.1 mg per dose. Mayrepe at to a maximum of 0.5 mg. Cardiac Arrest: 1 day to 8 years Epinephrine (0.1 mg/ml), 0.01 mg/kgIV/IO (do not exceed adult dosage) 9 to 14 years Epinephrine (0.1 mg/ml), 1.0 mg IV/IO Newborn Care: Epinephrine (0.1 mg/ml), 0.01 mg/kgIV/IO if heart rate is lessthan 60 after one (1) minute after evaluating airway for hypoxia and assessing bodytemperature for hypothermia. Epinephrine (0.1 mg/ml), 0.005 mg/kgIV/IO every 10 minutes for persistent hypotensi on as a basehospital order or in radio communicati on failure.",
    "html": "<div class='proto'>Anaphylactic reacti on (no palpable radial pulse and depressed level of consciousness): Epinephrine (<b>0.1 mg</b>/ml), <b>0.01 mg/kg</b><b>IV/IO</b>, no morethan <b>0.1 mg</b> per dose. Mayrepe at to a <b>maximum of <b>0.5 mg</b></b>. Cardiac Arrest: 1 day to 8 years Epinephrine (<b>0.1 mg</b>/ml), <b>0.01 mg/kg</b><b>IV/IO</b> (do not exceed adult dosage) 9 to 14 years Epinephrine (<b>0.1 mg</b>/ml), <b>1.0 mg</b> <b>IV/IO</b> Newborn Care: Epinephrine (<b>0.1 mg</b>/ml), <b>0.01 mg/kg</b><b>IV/IO</b> if heart rate is lessthan 60 after one (1) minute after evaluating airway for hypoxia and assessing bodytemperature for hypothermia. Epinephrine (<b>0.1 mg</b>/ml), <b>0.005 mg/kg</b><b>IV/IO</b> every 10 minutes for persistent hypotensi on as a basehospital order or in radio communicati on failure.</div>"
  },
  {
    "drug": "Epinephrine (0.01 mg/ml)",
    "population": "Pediatric",
    "page": 235,
    "text": "Postresuscitati on, profound shock and hypotensi on, for persistent shockdue to trauma where cardiac arrest is imminent (PushDose Epinephrine): Prep are Epinephrine 0.01 mg/ml soluti on by mixing 9 ml of normal saline with 1 ml of Epinephrine 0.1 mg/ml in a 10 ml syringe. Administer 0.1 ml/kg (do not exceed adult dosage), everyone (1) to five (5) minutes. Titrate to mainta in a SBPmore than 70 mmHg.",
    "html": "<div class='proto'>Postresuscitati on, profound shock and hypotensi on, for persistent shockdue to trauma where cardiac arrest is imminent (PushDose Epinephrine): Prep are Epinephrine <b>0.01 mg</b>/ml soluti on by mixing <b>9 ml</b> of normal saline with <b>1 ml</b> of Epinephrine <b>0.1 mg</b>/ml in a <b>10 ml</b> syringe. Administer <b>0.1 ml/kg</b> (do not exceed adult dosage), everyone (1) to five (5) minutes. Titrate to mainta in a SBPmore than 70 mmHg.</div>"
  },
  {
    "drug": "Fentanyl",
    "population": "Adult",
    "page": 235,
    "text": "Chest Pain (Presumed Ischemic Orig in): Fentanyl, 50 mcg slow IV/IO over one (1) minute. Mayrepe at every five (5) minutes titrated to pain, not to exceed 200 mcg. Fentanyl, 100 mcg IM/IN. Mayrepe at 50 mcg every 10 minutes titrated to pain, not to exceed 200 mcg. Acute traumatic injuries, acute abdominal/flank pain, burninjuries, Cancer pain, Sickle CellCrisis: Fentanyl, 50 mcg slow IV/IO push over one (1) minute. Mayrepe at every five (5) minutes titrated to pain, not to exceed 200 mcg IV/IO, or Fentanyl, 100 mcg IM/IN. Mayrepe at 50 mcg every 10 minutes titrated to pain, not to exceed 200 mcg. Pacing, synchronized cardioversi on: Fentanyl, 50 mcg slow IV/IO over one (1) minute. Mayrepe at in five (5) minutes titrated to pain, not to exceed 200 mcg. Fentanyl, 100 mcg IN. Mayrepe at 50 mcg every 10 minutes titrated to pain, not to exceed 200 mcg. Anycombinati on of IV/IO/IM/IN may be administered, not to exceed 200 mcg. Contact basehospital for additional orders and to discuss further treatment options.",
    "html": "<div class='proto'>Chest Pain (Presumed Ischemic Orig in): Fentanyl, <b>50 mcg</b> slow <b>IV/IO</b> over one (1) minute. Mayrepe at every five (5) minutes titrated to pain, <b>not to exceed <b>200 mcg</b></b>. Fentanyl, <b>100 mcg</b> <b>IM</b>/<b>IN</b>. Mayrepe at <b>50 mcg</b> every 10 minutes titrated to pain, <b>not to exceed <b>200 mcg</b></b>. Acute traumatic injuries, acute abdominal/flank pain, burninjuries, Cancer pain, Sickle CellCrisis: Fentanyl, <b>50 mcg</b> slow <b>IV/IO</b> push over one (1) minute. Mayrepe at every five (5) minutes titrated to pain, <b>not to exceed <b>200 mcg</b> <b>IV/IO</b>, or Fentanyl, <b>100 mcg</b></b> <b>IM</b>/<b>IN</b>. Mayrepe at <b>50 mcg</b> every 10 minutes titrated to pain, <b>not to exceed <b>200 mcg</b></b>. Pacing, synchronized cardioversi on: Fentanyl, <b>50 mcg</b> slow <b>IV/IO</b> over one (1) minute. Mayrepe at in five (5) minutes titrated to pain, <b>not to exceed <b>200 mcg</b></b>. Fentanyl, <b>100 mcg</b> <b>IN</b>. Mayrepe at <b>50 mcg</b> every 10 minutes titrated to pain, <b>not to exceed <b>200 mcg</b></b>. Anycombinati on of <b>IV/IO</b>/<b>IM</b>/<b>IN</b> may be administered, <b>not to exceed <b>200 mcg</b></b>. Contact basehospital for additional orders and to discuss further treatment options.</div>"
  },
  {
    "drug": "Fentanyl",
    "population": "Pediatric",
    "page": 236,
    "text": "Fentanyl, 0.5 mcg/kgslowIV/IO over one (1) minute. Mayrepe at in five (5) minutes titrated to pain, not to exceed 50 mcg for a single dose. Fentanyl, 1 mcg/kgIM/IN, mayrepe at every 10 minutes titrated to pain not to exceed 100 mcg for a single dose. Anycombinati on of IV/IO/IM/IN may be administered, not to exceed four (4) doses or cumulative maximum of 200 mcg. Contact basehospital for additional orders and to discuss further treatment options. G lucose - Oral - Adult (BLS, LALS, ALS) Adult with bloodg lucose lessthan 80 mg/dL: G lucose - Oral, one (1) tube for patients with an intactgag reflex and hypoglycemia. G lucose - Oral - Pediatric (BLS, LALS, ALS) Hypoglycemia - Neonates (0 - 4 weeks) with bloodg lucose lessthan 35 mg/dL or pediatric patients (morethan 4 weeks) with g lucose lessthan 60 mg/dL: G lucose - Oral, one (1) tube for patients with an intactgag reflex and hypoglycemia.",
    "html": "<div class='proto'>Fentanyl, <b>0.5 mcg/kg</b>slowIV/<b>IO</b> over one (1) minute. Mayrepe at in five (5) minutes titrated to pain, <b>not to exceed <b>50 mcg</b></b> for a single dose. Fentanyl, <b>1 mcg/kg</b><b>IM</b>/<b>IN</b>, mayrepe at every 10 minutes titrated to pain <b>not to exceed <b>100 mcg</b></b> for a single dose. Anycombinati on of <b>IV/IO</b>/<b>IM</b>/<b>IN</b> may be administered, <b>not to exceed four (4) doses or cumulative maximum of <b>200 mcg</b></b>. Contact basehospital for additional orders and to discuss further treatment options. G lucose - Oral - Adult (BLS, LALS, ALS) Adult with bloodg lucose lessthan <b>80 mg</b>/dL: G lucose - Oral, one (1) tube for patients with an intactgag reflex and hypoglycemia. G lucose - Oral - Pediatric (BLS, LALS, ALS) Hypoglycemia - Neonates (0 - 4 weeks) with bloodg lucose lessthan <b>35 mg</b>/dL or pediatric patients (morethan 4 weeks) with g lucose lessthan <b>60 mg</b>/dL: G lucose - Oral, one (1) tube for patients with an intactgag reflex and hypoglycemia.</div>"
  },
  {
    "drug": "G lucag on",
    "population": "Adult",
    "page": 236,
    "text": "G lucag on, 1 mg IM/SC/IN, if unable to establishIV. Mayadministerone (1) time only. Betablocker Poisoning (basehospital order only): G lucag on, 1 mg IV/IO",
    "html": "<div class='proto'>G lucag on, <b>1 mg</b> <b>IM</b>/SC/<b>IN</b>, if unable to establishIV. Mayadministerone (1) time only. Betablocker Poisoning (basehospital order only): G lucag on, <b>1 mg</b> <b>IV/IO</b></div>"
  },
  {
    "drug": "G lucag on",
    "population": "Pediatric",
    "page": 236,
    "text": "Hypoglycemia, if unable to establishIV: G lucag on, 0.03 mg/kgIM/IN, if unable to start an IV. May be repeatedone (1) time after 20 minutes for a combined maximum dose of 1 mg. Betablocker poisoning (basehospital order only): G lucag on, 0.03 mg/kgIV/IO Reference #\u2019s 4060, 4080, 7010, 7020, 13010 Ipratropium Bromide (Atrovent) Inhalati on Solutionuse with Albuterol Adult (ALS) Atrovent, 0.5 mg nebulized. Administerone (1) dose only. Ipratropium Bromide (Atrovent) Metered-DoseInhaler (MDI) use with Albuterol Adult (ALS) Whenused in combinati on with AlbuterolMDI useAlbuterol MDIdosing. Ipratropium Bromide (Atrovent) Inhalati on Solutionuse with Albuterol - Pediatric (ALS) 1 day to 12 months Atrovent, 0.25 mg nebulized. Administerone (1) dose only. 1 year to 14 years Atrovent, 0.5 mg nebulized. Administerone (1) dose only. Ipratropium Bromide (Atrovent) Metered-DoseInhaler (MDI) use with Albuterol - Pediatric (ALS) Whenused in combinati on with AlbuterolMDI useAlbuterol MDIdosing.",
    "html": "<div class='proto'>Hypoglycemia, if unable to establishIV: G lucag on, <b>0.03 mg/kg</b><b>IM</b>/<b>IN</b>, if unable to start an <b>IV</b>. May be repeatedone (1) time after 20 minutes for a combined <b>maximum dose of <b>1 mg</b></b>. Betablocker poisoning (basehospital order only): G lucag on, <b>0.03 mg/kg</b><b>IV/IO</b> Reference #\u2019s 4060, 4080, 7010, 7020, 13010 Ipratropium Bromide (Atrovent) Inhalati on Solutionuse with Albuterol Adult (ALS) Atrovent, <b>0.5 mg</b> <b>nebulized</b>. Administerone (1) dose only. Ipratropium Bromide (Atrovent) Metered-DoseInhaler (MDI) use with Albuterol Adult (ALS) Whenused in combinati on with AlbuterolMDI useAlbuterol MDIdosing. Ipratropium Bromide (Atrovent) Inhalati on Solutionuse with Albuterol - Pediatric (ALS) 1 day to 12 months Atrovent, <b>0.25 mg</b> <b>nebulized</b>. Administerone (1) dose only. 1 year to 14 years Atrovent, <b>0.5 mg</b> <b>nebulized</b>. Administerone (1) dose only. Ipratropium Bromide (Atrovent) Metered-DoseInhaler (MDI) use with Albuterol - Pediatric (ALS) Whenused in combinati on with AlbuterolMDI useAlbuterol MDIdosing.</div>"
  },
  {
    "drug": "Ketamine",
    "population": "Adult",
    "page": 237,
    "text": "Acute traumatic injury, acute abdominal/flank pain, burninjuries, cancer related pain and sickle cellcrisis: Ketamine, 0.3 mg/kg to a max of 30 mg in a 50 - 100 ml of NSviaIV over five (5) minutes. Mayrepeatone (1) time, after 15 minutes, if painscore remains at five (5) or higher. Do not administerIV P, IO, IM, or IN.",
    "html": "<div class='proto'>Acute traumatic injury, acute abdominal/flank pain, burninjuries, cancer related pain and sickle cellcrisis: Ketamine, <b>0.3 mg/kg</b> to a <b>max of <b>30 mg</b> in a 50 - <b>100 ml</b></b> of NSviaIV over five (5) minutes. Mayrepeatone (1) time, after 15 minutes, if painscore remains at five (5) or higher. Do not administerIV P, <b>IO</b>, <b>IM</b>, or <b>IN</b>.</div>"
  },
  {
    "drug": "Lidocaine",
    "population": "Adult",
    "page": 237,
    "text": "VT (pulseless)/VF: Initial Dose: Lidocaine, 1.5 mg/kgIV/IO For refractoryVT (pulseless)/VF, mayadminister an additional 0.75 mg/kgIV/IO, repe at one (1) time in five (5) to 10 minutes; maximum total dose of 3 mg/kg. V-Tach, WideComplex Tachycardia - with Pulses: Lidocaine, 1.5 mg/kgslowIV/IO Mayadminister an additional 0.75 mg/kgslowIV/IO; maximum total dose of 3 mg/kg.",
    "html": "<div class='proto'>VT (pulseless)/VF: Initial Dose: Lidocaine, <b>1.5 mg/kg</b><b>IV/IO</b> For refractoryVT (pulseless)/VF, mayadminister an additional <b>0.75 mg/kg</b><b>IV/IO</b>, repe at one (1) time in five (5) to 10 minutes; <b>maximum total dose of <b>3 mg</b></b>/kg. V-Tach, WideComplex Tachycardia - with Pulses: Lidocaine, <b>1.5 mg/kg</b>slowIV/<b>IO</b> Mayadminister an additional <b>0.75 mg/kg</b>slowIV/<b>IO</b>; <b>maximum total dose of <b>3 mg</b></b>/kg.</div>"
  },
  {
    "drug": "Lidocaine",
    "population": "Pediatric",
    "page": 238,
    "text": "Cardiac Arrest: 1 day to 8 years Lidocaine, 1.0 mg/kgIV/IO 9 to 14 years Lidocaine, 1.0 mg/kgIV/IO Mayrepe at Lidocaine at 0.5 mg/kg after five (5) minutes; maximum total dose of 3 mg/kg. Lidocaine 2% (Intravenous Soluti on) - Pediatric and Adult (ALS) Painassociated with IO infusi on: Lidocaine, 0.5 mg/kgslowIO push over two (2) minutes, not to exceed 40 mg total.",
    "html": "<div class='proto'>Cardiac Arrest: 1 day to 8 years Lidocaine, <b>1.0 mg/kg</b><b>IV/IO</b> 9 to 14 years Lidocaine, <b>1.0 mg/kg</b><b>IV/IO</b> Mayrepe at Lidocaine at <b>0.5 mg/kg</b> after five (5) minutes; <b>maximum total dose of <b>3 mg</b></b>/kg. Lidocaine 2% (Intravenous Soluti on) - Pediatric and Adult (ALS) Painassociated with <b>IO</b> infusi on: Lidocaine, <b>0.5 mg/kg</b>slowIO push over two (2) minutes, <b>not to exceed <b>40 mg</b></b> total.</div>"
  },
  {
    "drug": "Magnesium Sulfate",
    "population": "Adult",
    "page": 238,
    "text": "Polymorphic Ventricular Tachycardia: Magnesium Sulfate, 2 g mIV/IO bolus over five (5) minutes for polymorphicVT if prolongedQT is observed during sinus rhythm post-cardioversi on. Eclampsia (Seizure/Tonic/Clonic Activity): Magnesium Sulfate, 4 g mIV/IO slow IV push over three (3) to four (4) minutes. Magnesium Sulfate, 10 mg/minIV/IO drip to prevent continued seizures. Severe Asthma/Respiratory Distress (ALS) (basehospital order only): Magnesium Sulfate, 2 g mslow IV drip over 20 minutes. Do not repe at.",
    "html": "<div class='proto'>Polymorphic Ventricular Tachycardia: Magnesium Sulfate, <b>2 g</b> mIV/<b>IO</b> bolus over five (5) minutes for polymorphicVT if prolongedQT is observed during sinus rhythm post-cardioversi on. Eclampsia (Seizure/Tonic/Clonic Activity): Magnesium Sulfate, <b>4 g</b> mIV/<b>IO</b> slow <b>IV</b> push over three (3) to four (4) minutes. Magnesium Sulfate, <b>10 mg</b>/minIV/<b>IO</b> drip to prevent continued seizures. Severe Asthma/Respiratory Distress (ALS) (basehospital order only): Magnesium Sulfate, <b>2 g</b> mslow <b>IV</b> drip over 20 minutes. Do not repe at.</div>"
  },
  {
    "drug": "Midazolam (Versed)",
    "population": "Adult",
    "page": 238,
    "text": "Behavioral Emergencies, if patient meets criteria for potentially fatal and dangerous agitati on: Midazolam, 2.5 mg IV/IO. Mayrepe at in five (5) minutes, or Midazolam, 5 mg IM/IN. Mayrepe at in 10 minutes. Maximum of three (3) doses usingany combinati on of IV/IO/IM/IN may be administered. Contact basehospital for additional orders and to discuss further treatment options. PostROSC Agitati on (basehospital order only): Agitati on following ROSCth at hinders patient\u2019scare, i.e. biting or attempting to removeET tube/lines, Not to be used for sedati on during intubati on of anypatients. Midazolam, 2.5 mg IV/IO or Midazolam 5 mg IM/IN Patient musthave advanced airway (endotracheal tube or i-g el.) Repe at doserequires basehospital contact. Seizure: Midazolam, 2.5 mg IV/IO. Mayrepe at in five (5) minutes for continued seizure activity, or Midazolam, 5 mg IM/IN. Mayrepe at in 10 minutes for continued seizure activity. Assess patient for medicati on related reduced respiratory rate or hypotensi on. Maximum of three (3) doses usingany combinati on of IV/IO/IM/IN may be administered for continued seizure activity. Contact basehospital for additional orders and to discuss further treatment options. Pacing, synchronized cardioversi on: Midazolam, 2.5 mg slow IV/IO. Mayrepe at in five (5) minutes. Midazolam, 5 mg IM/IN. Mayrepe at in ten (10) minutes. Maximum of three (3) doses usingany combinati on of IV/IO/IM/IN may be administered. Contact basehospital for additional orders and to discuss further treatment options. CPAP: Midazolam, 1 mg IV/IO/IM/IN may be administeredone (1) time for anxiety related to applicati on of CPAP. Contact basehospital for additional orders.",
    "html": "<div class='proto'>Behavioral Emergencies, if patient meets criteria for potentially fatal and dangerous agitati on: Midazolam, <b>2.5 mg</b> <b>IV/IO</b>. Mayrepe at in five (5) minutes, or Midazolam, <b>5 mg</b> <b>IM</b>/<b>IN</b>. Mayrepe at in 10 minutes. Maximum of three (3) doses usingany combinati on of <b>IV/IO</b>/<b>IM</b>/<b>IN</b> may be administered. Contact basehospital for additional orders and to discuss further treatment options. PostROSC Agitati on (basehospital order only): Agitati on following ROSCth at hinders patient\u2019scare, i.e. biting or attempting to removeET tube/lines, Not to be used for sedati on during intubati on of anypatients. Midazolam, <b>2.5 mg</b> <b>IV/IO</b> or Midazolam <b>5 mg</b> <b>IM</b>/<b>IN</b> Patient musthave advanced airway (endotracheal tube or i-g el.) Repe at doserequires basehospital contact. Seizure: Midazolam, <b>2.5 mg</b> <b>IV/IO</b>. Mayrepe at in five (5) minutes for continued seizure activity, or Midazolam, <b>5 mg</b> <b>IM</b>/<b>IN</b>. Mayrepe at in 10 minutes for continued seizure activity. Assess patient for medicati on related reduced respiratory rate or hypotensi on. Maximum of three (3) doses usingany combinati on of <b>IV/IO</b>/<b>IM</b>/<b>IN</b> may be administered for continued seizure activity. Contact basehospital for additional orders and to discuss further treatment options. Pacing, synchronized cardioversi on: Midazolam, <b>2.5 mg</b> slow <b>IV/IO</b>. Mayrepe at in five (5) minutes. Midazolam, <b>5 mg</b> <b>IM</b>/<b>IN</b>. Mayrepe at in ten (10) minutes. Maximum of three (3) doses usingany combinati on of <b>IV/IO</b>/<b>IM</b>/<b>IN</b> may be administered. Contact basehospital for additional orders and to discuss further treatment options. CPAP: Midazolam, <b>1 mg</b> <b>IV/IO</b>/<b>IM</b>/<b>IN</b> may be administeredone (1) time for anxiety related to applicati on of CPAP. Contact basehospital for additional orders.</div>"
  },
  {
    "drug": "Midazolam (Versed)",
    "population": "Pediatric",
    "page": 239,
    "text": "Seizures: Midazolam, 0.1 mg/kgIV/IO with maximum dose 2.5 mg. Mayrepe at Midazolam in five (5) minutes, or Midazolam, 0.2 mg/kgIM/IN with maximum dose of 5 mg. Mayrepe at Midazolam in 10 minutes for continued seizure. Assess patient for medicati on related reduced respiratory rate or hypotensi on. Maximum of three (3) doses usingany combinati on of IV/IO/IM/IN may be administered for continued seizure activity. Contact basehospital for additional orders and to discuss further treatment options. Behavioral Emergencies, if patient meets criteria for potentially fatal and dangerous agitati on (basehospital order): Midazolam, 0.1 mg/kgIV/IO. Mayrepe at in five (5) minutes, or Midazolam, 0.2 mg/kgIM/IN. Mayrepe at in 10 minutes. Assess patient for medicati on related reduced respiratory rate or hypotensi on. Maximum of three (3) doses usingany combinati on of IV/IO/IM/IN may be administered. Not to exceed adult dose. Contact basehospital for additional orders and to discuss further treatment options.",
    "html": "<div class='proto'>Seizures: Midazolam, <b>0.1 mg/kg</b><b>IV/IO</b> with <b>maximum dose <b>2.5 mg</b></b>. Mayrepe at Midazolam in five (5) minutes, or Midazolam, <b>0.2 mg/kg</b><b>IM</b>/<b>IN</b> with <b>maximum dose of <b>5 mg</b></b>. Mayrepe at Midazolam in 10 minutes for continued seizure. Assess patient for medicati on related reduced respiratory rate or hypotensi on. Maximum of three (3) doses usingany combinati on of <b>IV/IO</b>/<b>IM</b>/<b>IN</b> may be administered for continued seizure activity. Contact basehospital for additional orders and to discuss further treatment options. Behavioral Emergencies, if patient meets criteria for potentially fatal and dangerous agitati on (basehospital order): Midazolam, <b>0.1 mg/kg</b><b>IV/IO</b>. Mayrepe at in five (5) minutes, or Midazolam, <b>0.2 mg/kg</b><b>IM</b>/<b>IN</b>. Mayrepe at in 10 minutes. Assess patient for medicati on related reduced respiratory rate or hypotensi on. Maximum of three (3) doses usingany combinati on of <b>IV/IO</b>/<b>IM</b>/<b>IN</b> may be administered. Not to exceed adult dose. Contact basehospital for additional orders and to discuss further treatment options.</div>"
  },
  {
    "drug": "Naloxone (Narcan)",
    "population": "Adult",
    "page": 240,
    "text": "For resoluti on of respiratory depressi on related to suspected opiate overdose: Naloxone, 0.5 mg IM/IN, mayrepe at Naloxone 0.5 mg IM/IN everytwo (2) to three (3) minutes if needed to improve respiratory effort. For suspected Fentanyl overdose with respiratory depressi on: Consider a loading dose of 4 mg IN Naloxone. If no signs of respiratory improvement, consider Naloxone 0.5 mg IM/IN everytwo (2) to three (3) minutes if needed. Do not exceed 10 mg of Naloxone total regardless of route administered.",
    "html": "<div class='proto'>For resoluti on of respiratory depressi on related to suspected opiate overdose: Naloxone, <b>0.5 mg</b> <b>IM</b>/<b>IN</b>, mayrepe at Naloxone <b>0.5 mg</b> <b>IM</b>/<b>IN</b> everytwo (2) to three (3) minutes if needed to improve respiratory effort. For suspected Fentanyl overdose with respiratory depressi on: Consider a loading dose of <b>4 mg</b> <b>IN</b> Naloxone. If no signs of respiratory improvement, consider Naloxone <b>0.5 mg</b> <b>IM</b>/<b>IN</b> everytwo (2) to three (3) minutes if needed. Do not exceed <b>10 mg</b> of Naloxone total regardless of route administered.</div>"
  },
  {
    "drug": "Naloxone (Narcan)",
    "population": "Adult",
    "page": 240,
    "text": "For resoluti on of respiratory depressi on related to suspected opiate overdose: Naloxone, 0.5 mg IV/IO/IM/IN, mayrepe at Naloxone 0.5 mg IV/IO/IM/IN everytwo (2) to three (3) minutes if needed to improve respiratory effort. For suspected Fentanyl overdose with respiratory depressi on: Consider a loading dose of 4 mg IN Naloxone, mayrepe at one (1) time. If no signs of respiratory improvement, consider Naloxone 0.5 mg IV/IO/IM/IN everytwo (2) to three (3) minutes if needed. Do not exceed 10 mg of Naloxone total regardless of route administered.",
    "html": "<div class='proto'>For resoluti on of respiratory depressi on related to suspected opiate overdose: Naloxone, <b>0.5 mg</b> <b>IV/IO</b>/<b>IM</b>/<b>IN</b>, mayrepe at Naloxone <b>0.5 mg</b> <b>IV/IO</b>/<b>IM</b>/<b>IN</b> everytwo (2) to three (3) minutes if needed to improve respiratory effort. For suspected Fentanyl overdose with respiratory depressi on: Consider a loading dose of <b>4 mg</b> <b>IN</b> Naloxone, mayrepe at one (1) time. If no signs of respiratory improvement, consider Naloxone <b>0.5 mg</b> <b>IV/IO</b>/<b>IM</b>/<b>IN</b> everytwo (2) to three (3) minutes if needed. Do not exceed <b>10 mg</b> of Naloxone total regardless of route administered.</div>"
  },
  {
    "drug": "Naloxone (Narcan)",
    "population": "Pediatric",
    "page": 240,
    "text": "For resoluti on of respiratory depressi on related to suspected opiate overdose: 1 day to 8 years Naloxone, 0.1 mg/kgIM/IN (do not exceed the adult dose of 0.5 mg per administrati on) 9 to 14 years Naloxone, 0.5 mg IM/IN Mayrepe at everytwo (2) to three (3) minutes if needed. Do not exceed the adult dosage of 10 mg total IM/IN.",
    "html": "<div class='proto'>For resoluti on of respiratory depressi on related to suspected opiate overdose: 1 day to 8 years Naloxone, <b>0.1 mg/kg</b><b>IM</b>/<b>IN</b> (do not exceed the adult dose of <b>0.5 mg</b> per administrati on) 9 to 14 years Naloxone, <b>0.5 mg</b> <b>IM</b>/<b>IN</b> Mayrepe at everytwo (2) to three (3) minutes if needed. Do not exceed the adult dosage of <b>10 mg</b> total <b>IM</b>/<b>IN</b>.</div>"
  },
  {
    "drug": "Naloxone (Narcan)",
    "population": "Pediatric",
    "page": 240,
    "text": "For resoluti on of respiratory depressi on related to suspected opiate overdose: 1 day to 8 years Naloxone, 0.1 mg/kgIV/IO/IM/IN (do not exceed the adult dose of 0.5 mg per administrati on) 9 to 14 years Naloxone, 0.5 mg IV/IO/IM/IN Mayrepe at everytwo (2) to three (3) minutes if needed. Do not exceed the adult dosage of 10 mg total IV/IO/IM/IN.",
    "html": "<div class='proto'>For resoluti on of respiratory depressi on related to suspected opiate overdose: 1 day to 8 years Naloxone, <b>0.1 mg/kg</b><b>IV/IO</b>/<b>IM</b>/<b>IN</b> (do not exceed the adult dose of <b>0.5 mg</b> per administrati on) 9 to 14 years Naloxone, <b>0.5 mg</b> <b>IV/IO</b>/<b>IM</b>/<b>IN</b> Mayrepe at everytwo (2) to three (3) minutes if needed. Do not exceed the adult dosage of <b>10 mg</b> total <b>IV/IO</b>/<b>IM</b>/<b>IN</b>.</div>"
  },
  {
    "drug": "Nitroglycer in (NTG)",
    "population": "Adult",
    "page": 241,
    "text": "Nitroglycer in, 0.4 mg sublingual/transmucosal. One (1) every three (3) minutes as needed. May be repeated as long as patient continues to havesigns of adequate tissue perfusi on. If a Right Ventricular Infarcti on is suspected, the use of nitrates requires basehospital contact. Nitroglycer in Paste, 1 inch (1 g m) transdermal, may not repe at. Nitroglycer in sublingual is the preferred route of administrati on for ACS. Nitro Paste is a one (1) timedose and intended for whensublingual cannot be easily administered (i.e., CPAP). Nitroglycer in is contraindicated if there are signs of inadequate tissue perfusi on or if sexual enhancement medications havebeen utilized with in the past 48 hours. Ondansetr on (Zofran) - Patients four (4) yearsold to Adult (ALS) Nausea/Vomiting: Ondansetr on, 4 mg slow IV/IO/ODTAllpatients four (4) to eight (8) yearsold: Mayadminister a total of 4 mg s of Ondansetr on pri or to basehospital contact. Allpatients nine (9) and older: Mayadminister Ondansetr on 4 mg; mayrepe at two (2) times, at 10 minute intervals, for a total of 12 mg spri or to basehospital contact. May be used as prophylactic treatment of nausea and vomiting associated with narcotic administrati on.",
    "html": "<div class='proto'>Nitroglycer in, <b>0.4 mg</b> sublingual/transmucosal. One (1) every three (3) minutes as needed. May be repeated as long as patient continues to havesigns of adequate tissue perfusi on. If a Right Ventricular Infarcti on is suspected, the use of nitrates requires basehospital contact. Nitroglycer in Paste, 1 inch (<b>1 g</b> m) transdermal, may not repe at. Nitroglycer in sublingual is the preferred route of administrati on for ACS. Nitro Paste is a one (1) timedose and intended for whensublingual cannot be easily administered (i.e., CPAP). Nitroglycer in is contraindicated if there are signs of inadequate tissue perfusi on or if sexual enhancement medications havebeen utilized with in the past 48 hours. Ondansetr on (Zofran) - Patients four (4) yearsold to Adult (ALS) Nausea/Vomiting: Ondansetr on, <b>4 mg</b> slow <b>IV/IO</b>/ODTAllpatients four (4) to eight (8) yearsold: Mayadminister a total of <b>4 mg</b> s of Ondansetr on pri or to basehospital contact. Allpatients nine (9) and older: Mayadminister Ondansetr on <b>4 mg</b>; mayrepe at two (2) times, at 10 minute intervals, for a total of <b>12 mg</b> spri or to basehospital contact. May be used as prophylactic treatment of nausea and vomiting associated with narcotic administrati on.</div>"
  },
  {
    "drug": "Sodium Bicarbonate",
    "population": "Adult",
    "page": 242,
    "text": "Tricyclic Poisoning (basehospital order only): Sodium Bicarbonate, 1 mEq/kgIV/IO For cardiac arrest with suspected metabolic acidosis, hyperkalemia or tricyclic poisoning (basehospital order only): Sodium Bicarbonate, 50 mEq IV/IO/ 50cc preload or 50cc single-dosevial Reference #\u2019s 7010, 7020, 14050",
    "html": "<div class='proto'>Tricyclic Poisoning (basehospital order only): Sodium Bicarbonate, <b>1 mEq/kg</b><b>IV/IO</b> For cardiac arrest with suspected metabolic acidosis, hyperkalemia or tricyclic poisoning (basehospital order only): Sodium Bicarbonate, <b>50 mEq</b> <b>IV/IO</b>/ <b>50cc</b> preload or <b>50cc</b> single-dosevial Reference #\u2019s 7010, 7020, 14050</div>"
  },
  {
    "drug": "Sodium Bicarbonate",
    "population": "Pediatric",
    "page": 242,
    "text": "Tricyclic Poisoning (basehospital order only): Sodium Bicarbonate, 1 mEq/kgIV/IO Reference #\u2019s 7010, 7020, 13010 Tranexamic Acid (TXA) - Patients 15 years of age and older (ALS) Signs of hemorrhagic shock meeting inclusi on criteria: AdministerTXA 1 g m in 50 - 100 ml of NSviaIV/IO over 10 minutes. Do not administerIVP as thiswill cause hypotensi on. Signs of postpartum hemorrhagic shock (basehospital order only) AdministerTXA 1 g m in 50 - 100 ml of NSviaIV/IO over 10 minutes. Do not administerIVP as thiswill cause hypotensi on. , APPENDIXI Medications for self-administrati on or with deployment of the ChemPack. Medications listed belowmay be used only for the purposes referenced by the associated ICEMA Treatment Protocol. Anyotheruse, route or doseother thanthose listed, must be ordered in consultati on with the BaseHospital physician.",
    "html": "<div class='proto'>Tricyclic Poisoning (basehospital order only): Sodium Bicarbonate, <b>1 mEq/kg</b><b>IV/IO</b> Reference #\u2019s 7010, 7020, 13010 Tranexamic Acid (TXA) - Patients 15 years of age and older (ALS) Signs of hemorrhagic shock meeting inclusi on criteria: AdministerTXA <b>1 g</b> m in 50 - <b>100 ml</b> of NSviaIV/<b>IO</b> over 10 minutes. Do not administerIVP as thiswill cause hypotensi on. Signs of postpartum hemorrhagic shock (basehospital order only) AdministerTXA <b>1 g</b> m in 50 - <b>100 ml</b> of NSviaIV/<b>IO</b> over 10 minutes. Do not administerIVP as thiswill cause hypotensi on. , APPENDIXI Medications for self-administrati on or with deployment of the ChemPack. Medications listed belowmay be used only for the purposes referenced by the associated ICEMA Treatment Protocol. Anyotheruse, route or doseother thanthose listed, must be ordered in consultati on with the BaseHospital physician.</div>"
  },
  {
    "drug": "Atropine",
    "population": "Pediatric",
    "page": 243,
    "text": "Known nerve agent/organophosphate poisoning with deployment of the ChemPack using: Two (2) or moremild symptoms: Administer the weight-based doselisted below as soon as an exposure is known or strongly suspected. If severe symptoms develop after the first dose, two (2) additional doses should be repeated in rapid successi on 10 minutes after the first dose; do not administer morethan three (3) doses. If profound anticholinergic effects occur in the absence of excessive bronchial secretions, further doses of atropine should be withheld. One (1) or moresevere symptoms: Immediately administer (3) three weight-based doses listed below in rapid successi on. Weight-based dosing: Lessthan 6.8 kg (lessthan 15 lbs): 0.25 mg, IM using multi-dosevial 6.8 to 18 kg (15 to 40 lbs): 0.5 mg, IM using AtroPen auto-inject or 18 to 41 kg (40 to 90 lbs): 1 mg, IM using AtroPen auto-inject or Morethan 41 kg (morethan 90 lbs): 2 mg, IM using multi-dosevial Symptoms of insecticide or nerve agent poisoning, as provided by manufacturer in the AtroPen product labeling, to g uide therapy: Mildsymptoms: Blurred visi on, bradycardia, breathing difficulties, chest tightness, coughing, drooling, miosis, muscular twitching, nausea, runny nose, salivati on increased, stomach cramps, tachycardia, teary eyes, trem or, vomiting, or wheezing. Severe symptoms: Breathing difficulties (severe), confused/strange behavi or, defecati on (involuntary), muscular twitching/g eneralized weakness (severe), respiratory secretions (severe), seizure, unconsciousness, urinati on (involuntary). NOTE: Infantsmay become drowsy or unconscious with muscle floppiness as opposed to muscle twitching.",
    "html": "<div class='proto'>Known nerve agent/organophosphate poisoning with deployment of the ChemPack using: Two (2) or moremild symptoms: Administer the weight-based doselisted below as soon as an exposure is known or strongly suspected. If severe symptoms develop after the first dose, two (2) additional doses should be repeated in rapid successi on 10 minutes after the first dose; do not administer morethan three (3) doses. If profound anticholinergic effects occur in the absence of excessive bronchial secretions, further doses of atropine should be withheld. One (1) or moresevere symptoms: Immediately administer (3) three weight-based doses listed below in rapid successi on. Weight-based dosing: Lessthan 6.8 kg (lessthan 15 lbs): <b>0.25 mg</b>, <b>IM</b> using multi-dosevial 6.8 to 18 kg (15 to 40 lbs): <b>0.5 mg</b>, <b>IM</b> using AtroPen auto-inject or 18 to 41 kg (40 to 90 lbs): <b>1 mg</b>, <b>IM</b> using AtroPen auto-inject or Morethan 41 kg (morethan 90 lbs): <b>2 mg</b>, <b>IM</b> using multi-dosevial Symptoms of insecticide or nerve agent poisoning, as provided by manufacturer in the AtroPen product labeling, to g uide therapy: Mildsymptoms: Blurred visi on, bradycardia, breathing difficulties, chest tightness, coughing, drooling, miosis, muscular twitching, nausea, runny nose, salivati on increased, stomach cramps, tachycardia, teary eyes, trem or, vomiting, or wheezing. Severe symptoms: Breathing difficulties (severe), confused/strange behavi or, defecati on (involuntary), muscular twitching/g eneralized weakness (severe), respiratory secretions (severe), seizure, unconsciousness, urinati on (involuntary). NOTE: Infantsmay become drowsy or unconscious with muscle floppiness as opposed to muscle twitching.</div>"
  },
  {
    "drug": "Diazepam (Valium)",
    "population": "Adult",
    "page": 243,
    "text": "For seizures associated with nerve agent/organophosphate exposure ONLY with the deployment of the ChemPack: Diazepam 10 mg (5 mg/ml) auto-injectorIM (if IV is unavailable), or Diazepam 2.5 mg IV",
    "html": "<div class='proto'>For seizures associated with nerve agent/organophosphate exposure ONLY with the deployment of the ChemPack: Diazepam <b>10 mg</b> (<b>5 mg</b>/ml) auto-injectorIM (if <b>IV</b> is unavailable), or Diazepam <b>2.5 mg</b> <b>IV</b></div>"
  }
]